Table 1.
Total (n = 88 *) | ||
---|---|---|
Male | 63 (72%) | |
Race | Caucasian | 70 (80%) |
African American | 5 (6%) | |
Asian | 2 (2%) | |
Hispanic | 3 (3%) | |
Unknown | 8 (9%) | |
Stage | 1 | 6 (7%) |
2 | 12 (14%) | |
3 | 12 (14%) | |
4 | 58 (65%) | |
Chemotherapy | 71 (81%) | |
Surgery | 74 (84%) | |
Radiation | 30 (34%) |
Patient baseline clinical–pathological characteristics. * Of 93 total patients, 88 patients had detectable iCTCs.